Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Choo Chee Kong | 0001970632 | Mar-31-2023 | director, 10 percent owner |
Zeng Jieming | 0001970819 | Mar-31-2023 | director, officer: CSO and CMO |
Wang Shu | 0001972300 | Mar-31-2023 | 10 percent owner |
Tan Wee Kiat | 0001973162 | Mar-31-2023 | director, officer: Chief Operating Officer |
Toh Keng Kiat | 0001973295 | Mar-31-2023 | director |
Glorious Finance Ltd | 0001973345 | Mar-31-2023 | 10 percent owner |
Luk Lucas Tien Wee | 0001973388 | Mar-31-2023 | director, officer: Chief Clinical Officer |
Leong Mark Kei Wei | 0001973389 | Mar-31-2023 | director |
Yew Chak Hua | 0001973390 | Mar-31-2023 | director |
Loh Yuin Han | 0001973540 | Mar-31-2023 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by CytoMed Therapeutics Pte. Ltd.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001493152-24-006597 (34 Act) Size: 86 KB |
Feb-14-2024 | 24637400 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001493152-24-006596 (34 Act) Size: 77 KB |
Feb-14-2024 | 24637399 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001493152-24-006595 (34 Act) Size: 82 KB |
Feb-14-2024 | 24637401 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001493152-24-006594 (34 Act) Size: 104 KB |
Feb-14-2024 | 24637403 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-24-004055 (34 Act) Size: 88 KB |
Jan-29-2024 | 24570047 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-23-041779 (34 Act) Size: 352 KB |
Nov-17-2023 | 231416761 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-23-033542 (34 Act) Size: 37 KB |
Sep-25-2023 | 231273168 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-23-026165 (34 Act) Size: 53 KB |
Aug-01-2023 | 231129670 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-23-023506 (34 Act) Size: 52 KB |
Jul-06-2023 | 231072108 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001493152-23-018344 (34 Act) Size: 76 KB |
May-19-2023 | 23940392 |
20-F | Document | Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001493152-23-015042 (34 Act) Size: 18022 KB |
May-01-2023 | 23875343 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001493152-23-013398 (34 Act) Size: 63 KB |
Apr-24-2023 | 23840929 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001493152-23-013202 (34 Act) Size: 113 KB |
Apr-21-2023 | 23836088 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-23-012811 (34 Act) Size: 807 KB |
Apr-18-2023 | 23827826 |
424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001493152-23-012534 (33 Act) Size: 9475 KB |
Apr-17-2023 | 23823986 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-23-012433 ( Act) Size: 2 KB |
Apr-17-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-23-012430 ( Act) Size: 2 KB |
Apr-17-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-23-012356 ( Act) Size: 3 KB |
Apr-14-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-23-012350 ( Act) Size: 2 KB |
Apr-14-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001493152-23-012347 ( Act) Size: 5 KB |
Apr-14-2023 |
Recent 20 filings. View all CytoMed Therapeutics Pte. Ltd. filings
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by